Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Calgranulin B | 11 | 2020 | 86 | 1.770 |
Why?
|
Plaque, Atherosclerotic | 15 | 2024 | 1532 | 1.360 |
Why?
|
Calgranulin A | 7 | 2015 | 80 | 1.330 |
Why?
|
Coronary Angiography | 18 | 2024 | 4471 | 1.010 |
Why?
|
Blood Platelets | 11 | 2016 | 2479 | 0.840 |
Why?
|
Angioplasty, Balloon, Coronary | 6 | 2015 | 1725 | 0.800 |
Why?
|
Coronary Artery Disease | 18 | 2024 | 6403 | 0.790 |
Why?
|
Macrophages | 14 | 2020 | 5767 | 0.740 |
Why?
|
Endothelium, Vascular | 14 | 2023 | 4431 | 0.740 |
Why?
|
Coronary Restenosis | 3 | 2018 | 396 | 0.700 |
Why?
|
Tomography, Optical Coherence | 9 | 2024 | 2917 | 0.690 |
Why?
|
Platelet Aggregation Inhibitors | 7 | 2017 | 2751 | 0.660 |
Why?
|
Cell-Derived Microparticles | 1 | 2020 | 161 | 0.630 |
Why?
|
Atherosclerosis | 12 | 2022 | 3407 | 0.600 |
Why?
|
Coronary Occlusion | 4 | 2022 | 304 | 0.600 |
Why?
|
Thrombosis | 9 | 2020 | 2942 | 0.600 |
Why?
|
Coronary Vessels | 12 | 2024 | 3096 | 0.560 |
Why?
|
Lipoproteins, LDL | 1 | 2020 | 642 | 0.560 |
Why?
|
Platelet Aggregation | 3 | 2013 | 771 | 0.480 |
Why?
|
Tunica Intima | 7 | 2018 | 459 | 0.480 |
Why?
|
Myocardial Infarction | 12 | 2022 | 11461 | 0.460 |
Why?
|
Ticlopidine | 4 | 2017 | 730 | 0.440 |
Why?
|
Endothelial Cells | 10 | 2021 | 3549 | 0.420 |
Why?
|
Thrombin | 2 | 2020 | 591 | 0.380 |
Why?
|
Thiophenes | 2 | 2012 | 569 | 0.340 |
Why?
|
Femoral Artery | 4 | 2010 | 826 | 0.330 |
Why?
|
Coronary Stenosis | 2 | 2016 | 794 | 0.330 |
Why?
|
Platelet Function Tests | 1 | 2011 | 271 | 0.320 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2010 | 244 | 0.310 |
Why?
|
Thromboplastin | 3 | 2020 | 286 | 0.290 |
Why?
|
Membrane Glycoproteins | 5 | 2010 | 3701 | 0.290 |
Why?
|
Heart Valve Prosthesis | 1 | 2016 | 1462 | 0.290 |
Why?
|
P-Selectin | 5 | 2011 | 597 | 0.280 |
Why?
|
Neovascularization, Physiologic | 4 | 2019 | 1349 | 0.280 |
Why?
|
Mice, Inbred C57BL | 30 | 2020 | 22174 | 0.280 |
Why?
|
Toll-Like Receptors | 1 | 2010 | 589 | 0.270 |
Why?
|
von Willebrand Factor | 1 | 2010 | 673 | 0.270 |
Why?
|
Stents | 8 | 2022 | 3179 | 0.260 |
Why?
|
Aortic Valve | 1 | 2016 | 1955 | 0.260 |
Why?
|
Chest Pain | 1 | 2012 | 1091 | 0.250 |
Why?
|
Chemotaxis, Leukocyte | 4 | 2012 | 662 | 0.250 |
Why?
|
Inflammation | 13 | 2015 | 10774 | 0.250 |
Why?
|
Vasculitis | 1 | 2009 | 521 | 0.240 |
Why?
|
Coronary Circulation | 2 | 2024 | 1569 | 0.240 |
Why?
|
Drug Monitoring | 1 | 2011 | 962 | 0.240 |
Why?
|
Macrophage-1 Antigen | 3 | 2012 | 285 | 0.230 |
Why?
|
Tetrazoles | 1 | 2010 | 909 | 0.230 |
Why?
|
Acute Coronary Syndrome | 4 | 2013 | 2190 | 0.220 |
Why?
|
Neutrophil Infiltration | 3 | 2017 | 390 | 0.220 |
Why?
|
Piperazines | 2 | 2012 | 2523 | 0.220 |
Why?
|
Terminology as Topic | 1 | 2011 | 1530 | 0.220 |
Why?
|
Platelet Glycoprotein GPIb-IX Complex | 3 | 2010 | 144 | 0.220 |
Why?
|
Aspirin | 3 | 2017 | 3133 | 0.210 |
Why?
|
Hemorrhage | 3 | 2017 | 3424 | 0.210 |
Why?
|
Early Growth Response Transcription Factors | 2 | 2013 | 32 | 0.200 |
Why?
|
Mice, Knockout | 20 | 2017 | 14417 | 0.200 |
Why?
|
Drug-Eluting Stents | 4 | 2017 | 681 | 0.200 |
Why?
|
Mice | 40 | 2021 | 81539 | 0.190 |
Why?
|
E-Selectin | 4 | 2015 | 576 | 0.190 |
Why?
|
Purinergic P2Y Receptor Antagonists | 3 | 2016 | 284 | 0.190 |
Why?
|
Collagen Type IV | 1 | 2021 | 126 | 0.190 |
Why?
|
Platelet Adhesiveness | 2 | 2008 | 154 | 0.180 |
Why?
|
Myocytes, Smooth Muscle | 3 | 2016 | 699 | 0.180 |
Why?
|
Kruppel-Like Transcription Factors | 3 | 2013 | 504 | 0.180 |
Why?
|
Lithotripsy | 1 | 2021 | 140 | 0.180 |
Why?
|
Carotid Artery Diseases | 5 | 2018 | 877 | 0.180 |
Why?
|
MicroRNAs | 4 | 2019 | 3816 | 0.180 |
Why?
|
Heart Injuries | 1 | 2022 | 206 | 0.170 |
Why?
|
Pyridazines | 1 | 2022 | 202 | 0.170 |
Why?
|
Humans | 77 | 2024 | 761596 | 0.170 |
Why?
|
Adenosine | 2 | 2015 | 808 | 0.160 |
Why?
|
Calpain | 1 | 1999 | 146 | 0.160 |
Why?
|
Immunity, Innate | 2 | 2012 | 3066 | 0.160 |
Why?
|
Hemodynamics | 3 | 2020 | 4160 | 0.160 |
Why?
|
Animals | 46 | 2021 | 168475 | 0.160 |
Why?
|
Leukocyte Rolling | 2 | 2015 | 69 | 0.150 |
Why?
|
Graft Rejection | 1 | 2011 | 4446 | 0.150 |
Why?
|
Neutrophils | 5 | 2018 | 3767 | 0.150 |
Why?
|
Heart Transplantation | 1 | 2011 | 3233 | 0.150 |
Why?
|
Cardiovascular Diseases | 4 | 2011 | 15502 | 0.150 |
Why?
|
Receptors, IgG | 3 | 2012 | 559 | 0.150 |
Why?
|
Arterial Occlusive Diseases | 1 | 2022 | 748 | 0.150 |
Why?
|
Hydrolases | 1 | 2018 | 147 | 0.140 |
Why?
|
Signal Transduction | 12 | 2019 | 23447 | 0.140 |
Why?
|
Drug Carriers | 1 | 2021 | 706 | 0.140 |
Why?
|
Leukocytes | 4 | 2011 | 2026 | 0.140 |
Why?
|
Myeloid Progenitor Cells | 3 | 2012 | 113 | 0.140 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2022 | 686 | 0.140 |
Why?
|
Cell Adhesion | 6 | 2014 | 3088 | 0.140 |
Why?
|
Enzyme Inhibitors | 2 | 2021 | 3713 | 0.140 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2016 | 120 | 0.140 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2020 | 323 | 0.140 |
Why?
|
Flow Cytometry | 5 | 2020 | 5870 | 0.140 |
Why?
|
Treatment Outcome | 18 | 2022 | 64685 | 0.130 |
Why?
|
Forkhead Transcription Factors | 3 | 2015 | 1616 | 0.130 |
Why?
|
Ultrasonography, Interventional | 5 | 2023 | 1496 | 0.130 |
Why?
|
Bone Marrow Cells | 3 | 2013 | 2417 | 0.130 |
Why?
|
Muscle, Smooth, Vascular | 3 | 2016 | 1492 | 0.130 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2019 | 705 | 0.130 |
Why?
|
Neovascularization, Pathologic | 2 | 2019 | 2645 | 0.130 |
Why?
|
Catheterization, Peripheral | 1 | 2019 | 343 | 0.130 |
Why?
|
Drug Resistance | 2 | 2013 | 1596 | 0.130 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2016 | 42 | 0.130 |
Why?
|
Imidazoles | 1 | 2022 | 1180 | 0.130 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 687 | 0.130 |
Why?
|
Hyperplasia | 2 | 2016 | 1152 | 0.130 |
Why?
|
Monocytes | 3 | 2009 | 2570 | 0.130 |
Why?
|
Oxygenases | 1 | 2015 | 59 | 0.120 |
Why?
|
Cell Proliferation | 8 | 2019 | 10451 | 0.120 |
Why?
|
Adenosine Monophosphate | 1 | 2016 | 231 | 0.120 |
Why?
|
Granulocyte-Macrophage Progenitor Cells | 2 | 2011 | 21 | 0.120 |
Why?
|
Toll-Like Receptor 2 | 1 | 2017 | 347 | 0.120 |
Why?
|
Male | 36 | 2024 | 360846 | 0.120 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2014 | 103 | 0.120 |
Why?
|
Synovitis | 1 | 2015 | 217 | 0.120 |
Why?
|
S-Nitrosothiols | 1 | 2014 | 35 | 0.110 |
Why?
|
Cell Movement | 6 | 2019 | 5205 | 0.110 |
Why?
|
Collagen | 2 | 2013 | 2638 | 0.110 |
Why?
|
Ulcer | 1 | 2015 | 204 | 0.110 |
Why?
|
Graft Occlusion, Vascular | 1 | 2017 | 537 | 0.110 |
Why?
|
Antiphospholipid Syndrome | 1 | 2015 | 165 | 0.110 |
Why?
|
Nitric Oxide Donors | 1 | 2014 | 126 | 0.110 |
Why?
|
Smad1 Protein | 1 | 2013 | 81 | 0.110 |
Why?
|
Arthritis, Experimental | 1 | 2015 | 291 | 0.110 |
Why?
|
Transcription Factor RelA | 1 | 2014 | 254 | 0.110 |
Why?
|
Integrin alpha4beta1 | 1 | 2013 | 119 | 0.110 |
Why?
|
Diabetes Complications | 1 | 2020 | 1315 | 0.110 |
Why?
|
Blood Flow Velocity | 1 | 2017 | 1371 | 0.110 |
Why?
|
Ossification, Heterotopic | 1 | 2015 | 235 | 0.110 |
Why?
|
Annexin A5 | 1 | 2013 | 103 | 0.110 |
Why?
|
Cytoplasmic Vesicles | 1 | 2013 | 73 | 0.110 |
Why?
|
Nanoparticles | 3 | 2021 | 1958 | 0.100 |
Why?
|
Algorithms | 4 | 2022 | 14033 | 0.100 |
Why?
|
Carotid Artery Injuries | 1 | 2013 | 96 | 0.100 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 1551 | 0.100 |
Why?
|
Protein Kinase Inhibitors | 2 | 2022 | 5672 | 0.100 |
Why?
|
Salicylates | 1 | 2013 | 127 | 0.100 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2013 | 377 | 0.100 |
Why?
|
Internationality | 1 | 2017 | 1001 | 0.100 |
Why?
|
Peripheral Arterial Disease | 2 | 2021 | 1273 | 0.100 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2017 | 499 | 0.100 |
Why?
|
Th17 Cells | 2 | 2015 | 794 | 0.100 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2011 | 102 | 0.100 |
Why?
|
Paracrine Communication | 1 | 2013 | 277 | 0.100 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2011 | 93 | 0.100 |
Why?
|
Cells, Cultured | 10 | 2021 | 18966 | 0.090 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2011 | 509 | 0.090 |
Why?
|
Antibodies | 3 | 2012 | 2418 | 0.090 |
Why?
|
Serum | 1 | 2012 | 209 | 0.090 |
Why?
|
Disease Models, Animal | 11 | 2021 | 18255 | 0.090 |
Why?
|
RNA, Messenger | 5 | 2015 | 12794 | 0.090 |
Why?
|
Receptors, Retinoic Acid | 1 | 2011 | 224 | 0.090 |
Why?
|
Apolipoprotein C-III | 1 | 2012 | 211 | 0.090 |
Why?
|
Apolipoproteins E | 5 | 2015 | 1443 | 0.090 |
Why?
|
Antigen-Antibody Complex | 1 | 2012 | 510 | 0.090 |
Why?
|
Histocompatibility | 1 | 2011 | 317 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2457 | 0.090 |
Why?
|
Clinical Trials as Topic | 3 | 2011 | 8002 | 0.090 |
Why?
|
Nanotechnology | 2 | 2021 | 714 | 0.090 |
Why?
|
Middle Aged | 16 | 2024 | 220921 | 0.090 |
Why?
|
Shear Strength | 1 | 2010 | 160 | 0.090 |
Why?
|
Glutathione Peroxidase | 1 | 2011 | 258 | 0.090 |
Why?
|
Cathepsins | 1 | 2011 | 241 | 0.080 |
Why?
|
Vascular System Injuries | 1 | 2013 | 246 | 0.080 |
Why?
|
Drug Approval | 1 | 2016 | 814 | 0.080 |
Why?
|
Brachytherapy | 1 | 2017 | 1223 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2014 | 4352 | 0.080 |
Why?
|
Microbubbles | 1 | 2010 | 135 | 0.080 |
Why?
|
Cholesterol, LDL | 2 | 2015 | 2382 | 0.080 |
Why?
|
Female | 23 | 2024 | 392705 | 0.080 |
Why?
|
Albumins | 1 | 2012 | 575 | 0.080 |
Why?
|
T-Box Domain Proteins | 1 | 2011 | 469 | 0.080 |
Why?
|
Transcription Factors | 3 | 2014 | 12130 | 0.080 |
Why?
|
Coccidiostats | 1 | 2008 | 3 | 0.080 |
Why?
|
Sulfadiazine | 1 | 2008 | 18 | 0.080 |
Why?
|
Heart-Assist Devices | 1 | 2019 | 1287 | 0.080 |
Why?
|
Aorta | 2 | 2013 | 2041 | 0.080 |
Why?
|
Coronary Thrombosis | 1 | 2011 | 440 | 0.080 |
Why?
|
Aged | 12 | 2024 | 169310 | 0.080 |
Why?
|
Gadolinium DTPA | 1 | 2012 | 823 | 0.080 |
Why?
|
Matrix Metalloproteinases | 1 | 2011 | 393 | 0.080 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2013 | 842 | 0.080 |
Why?
|
Endocytosis | 1 | 2012 | 957 | 0.080 |
Why?
|
Cardiovascular System | 1 | 2015 | 834 | 0.070 |
Why?
|
Hepatocytes | 1 | 2015 | 1233 | 0.070 |
Why?
|
Tyrosine | 1 | 2012 | 1440 | 0.070 |
Why?
|
NF-kappa B | 2 | 2013 | 2490 | 0.070 |
Why?
|
Osteoarthritis | 1 | 2015 | 1063 | 0.070 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2011 | 485 | 0.070 |
Why?
|
Wound Healing | 1 | 2019 | 2805 | 0.070 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2011 | 629 | 0.070 |
Why?
|
Metal Nanoparticles | 1 | 2012 | 399 | 0.070 |
Why?
|
Cadherins | 1 | 2012 | 903 | 0.070 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2011 | 1435 | 0.070 |
Why?
|
Ureteral Calculi | 1 | 2008 | 114 | 0.070 |
Why?
|
Peripheral Vascular Diseases | 1 | 2010 | 488 | 0.070 |
Why?
|
Quinolines | 1 | 2012 | 765 | 0.070 |
Why?
|
Drug Therapy, Combination | 3 | 2015 | 6312 | 0.070 |
Why?
|
Adiponectin | 1 | 2012 | 1113 | 0.070 |
Why?
|
Standard of Care | 1 | 2010 | 551 | 0.070 |
Why?
|
Th1 Cells | 1 | 2012 | 1036 | 0.070 |
Why?
|
Heart Diseases | 1 | 2019 | 2781 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 10212 | 0.070 |
Why?
|
Platelet Activation | 1 | 2010 | 645 | 0.070 |
Why?
|
Ligands | 4 | 2015 | 3272 | 0.070 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1749 | 0.070 |
Why?
|
Magnetics | 1 | 2009 | 599 | 0.070 |
Why?
|
Hypertension, Pulmonary | 1 | 2017 | 1578 | 0.070 |
Why?
|
Interleukin-17 | 1 | 2012 | 912 | 0.070 |
Why?
|
Hindlimb | 3 | 2014 | 513 | 0.060 |
Why?
|
Ischemia | 2 | 2011 | 1884 | 0.060 |
Why?
|
Heptanoic Acids | 1 | 2007 | 344 | 0.060 |
Why?
|
Pravastatin | 1 | 2007 | 392 | 0.060 |
Why?
|
Leukocytes, Mononuclear | 1 | 2012 | 1844 | 0.060 |
Why?
|
Comparative Effectiveness Research | 1 | 2010 | 709 | 0.060 |
Why?
|
Drug Interactions | 1 | 2010 | 1416 | 0.060 |
Why?
|
Predictive Value of Tests | 4 | 2023 | 15266 | 0.060 |
Why?
|
Patient Care Planning | 1 | 2010 | 909 | 0.060 |
Why?
|
Protein Binding | 4 | 2021 | 9353 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1651 | 0.060 |
Why?
|
Clinical Protocols | 1 | 2010 | 1440 | 0.060 |
Why?
|
Proton Pump Inhibitors | 1 | 2010 | 532 | 0.060 |
Why?
|
Emergency Medical Services | 2 | 2015 | 1923 | 0.060 |
Why?
|
Aged, 80 and over | 5 | 2022 | 58984 | 0.060 |
Why?
|
Calcinosis | 1 | 2013 | 1469 | 0.060 |
Why?
|
Thrombolytic Therapy | 2 | 2010 | 2064 | 0.060 |
Why?
|
Guidelines as Topic | 1 | 2010 | 1386 | 0.060 |
Why?
|
Bone Marrow Transplantation | 3 | 2018 | 2693 | 0.060 |
Why?
|
Immunoconjugates | 1 | 2012 | 953 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 1 | 2012 | 1802 | 0.060 |
Why?
|
Blotting, Western | 3 | 2016 | 5035 | 0.060 |
Why?
|
Myocardium | 1 | 2017 | 4725 | 0.060 |
Why?
|
Solubility | 2 | 2012 | 1091 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7391 | 0.060 |
Why?
|
Kidney Calculi | 1 | 2008 | 463 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2811 | 0.060 |
Why?
|
Tissue Distribution | 2 | 2021 | 2264 | 0.050 |
Why?
|
Transplantation, Homologous | 1 | 2011 | 4807 | 0.050 |
Why?
|
Biosensing Techniques | 1 | 2009 | 650 | 0.050 |
Why?
|
Mice, Inbred BALB C | 1 | 2011 | 6214 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2013 | 4369 | 0.050 |
Why?
|
Membrane Proteins | 3 | 2013 | 7859 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2011 | 11530 | 0.050 |
Why?
|
Macrophage Activation | 2 | 2020 | 553 | 0.050 |
Why?
|
Antibodies, Neutralizing | 1 | 2012 | 1943 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3359 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2012 | 1809 | 0.050 |
Why?
|
Cytokines | 3 | 2012 | 7396 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2872 | 0.050 |
Why?
|
Calcium-Binding Proteins | 2 | 2012 | 1069 | 0.050 |
Why?
|
Risk Factors | 7 | 2017 | 74213 | 0.050 |
Why?
|
Liver | 2 | 2015 | 7528 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2010 | 3514 | 0.050 |
Why?
|
Pyrroles | 1 | 2007 | 1125 | 0.050 |
Why?
|
Culture Media, Conditioned | 2 | 2013 | 522 | 0.050 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2014 | 691 | 0.050 |
Why?
|
Graft Survival | 1 | 2011 | 3820 | 0.050 |
Why?
|
Basement Membrane | 1 | 2021 | 349 | 0.050 |
Why?
|
Thrombectomy | 2 | 2015 | 705 | 0.040 |
Why?
|
Drug Compounding | 1 | 2021 | 246 | 0.040 |
Why?
|
Risk Assessment | 5 | 2015 | 23996 | 0.040 |
Why?
|
Mice, Transgenic | 4 | 2016 | 9542 | 0.040 |
Why?
|
Stem Cells | 1 | 2013 | 3524 | 0.040 |
Why?
|
Antigens, CD34 | 2 | 2013 | 658 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2005 | 13446 | 0.040 |
Why?
|
Off-Label Use | 1 | 2021 | 185 | 0.040 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2012 | 2155 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5799 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2013 | 546 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4243 | 0.040 |
Why?
|
Saphenous Vein | 2 | 2012 | 516 | 0.040 |
Why?
|
Radial Artery | 1 | 2021 | 187 | 0.040 |
Why?
|
Alkylation | 1 | 1998 | 84 | 0.040 |
Why?
|
Molecular Sequence Data | 3 | 2005 | 17635 | 0.040 |
Why?
|
T-Lymphocytes | 2 | 2013 | 10194 | 0.040 |
Why?
|
Prospective Studies | 6 | 2022 | 54423 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 13642 | 0.040 |
Why?
|
Surface Properties | 1 | 2021 | 1161 | 0.040 |
Why?
|
Contrast Media | 1 | 2012 | 5307 | 0.040 |
Why?
|
Patient Selection | 1 | 2011 | 4244 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2017 | 4853 | 0.040 |
Why?
|
Fluorescence Polarization | 1 | 1998 | 140 | 0.040 |
Why?
|
Catheters | 1 | 2021 | 427 | 0.040 |
Why?
|
Calcium | 3 | 2013 | 5722 | 0.040 |
Why?
|
Punctures | 1 | 2019 | 366 | 0.040 |
Why?
|
Lipids | 1 | 2009 | 3341 | 0.040 |
Why?
|
Collateral Circulation | 1 | 2019 | 294 | 0.040 |
Why?
|
Cell Separation | 2 | 2015 | 1720 | 0.040 |
Why?
|
Solutions | 1 | 1998 | 412 | 0.040 |
Why?
|
Precipitin Tests | 1 | 1998 | 813 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2011 | 4580 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2019 | 3492 | 0.040 |
Why?
|
Time Factors | 5 | 2022 | 39969 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2011 | 3080 | 0.040 |
Why?
|
Odds Ratio | 3 | 2022 | 9647 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 851 | 0.040 |
Why?
|
Repressor Proteins | 1 | 2008 | 2986 | 0.040 |
Why?
|
Exocytosis | 1 | 1999 | 320 | 0.040 |
Why?
|
Antigens, CD | 2 | 2006 | 4001 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3246 | 0.040 |
Why?
|
Deoxyribonuclease I | 1 | 2018 | 224 | 0.040 |
Why?
|
Injections, Intra-Arterial | 1 | 2017 | 182 | 0.040 |
Why?
|
Vascular Diseases | 1 | 2005 | 1161 | 0.040 |
Why?
|
Gene Expression Regulation | 5 | 2014 | 11904 | 0.040 |
Why?
|
Dimerization | 1 | 1998 | 891 | 0.030 |
Why?
|
Kidney | 1 | 2012 | 7048 | 0.030 |
Why?
|
Rats, Zucker | 1 | 2016 | 131 | 0.030 |
Why?
|
Insulin Resistance | 3 | 2016 | 3964 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 3530 | 0.030 |
Why?
|
Spectrometry, Fluorescence | 1 | 1998 | 685 | 0.030 |
Why?
|
Cytoplasmic Granules | 1 | 1999 | 574 | 0.030 |
Why?
|
DNA-Binding Proteins | 2 | 2011 | 9610 | 0.030 |
Why?
|
CHO Cells | 1 | 1998 | 1387 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2016 | 510 | 0.030 |
Why?
|
Peptides | 1 | 2008 | 4358 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2015 | 9420 | 0.030 |
Why?
|
Phenotype | 2 | 2010 | 16592 | 0.030 |
Why?
|
Chronic Disease | 2 | 2021 | 9319 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5841 | 0.030 |
Why?
|
Cholesterol, Dietary | 1 | 2015 | 224 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2012 | 1126 | 0.030 |
Why?
|
Lipid Metabolism, Inborn Errors | 1 | 2015 | 123 | 0.030 |
Why?
|
Cricetinae | 1 | 1998 | 2423 | 0.030 |
Why?
|
Phosphorylation | 2 | 2019 | 8321 | 0.030 |
Why?
|
SOXF Transcription Factors | 1 | 2014 | 31 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1827 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2016 | 1379 | 0.030 |
Why?
|
Rabbits | 2 | 2012 | 4772 | 0.030 |
Why?
|
Osteomyelitis | 1 | 2018 | 407 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2020 | 1119 | 0.030 |
Why?
|
Rats | 3 | 2016 | 23741 | 0.030 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2014 | 88 | 0.030 |
Why?
|
Blood Pressure | 1 | 2009 | 8481 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2015 | 878 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39106 | 0.030 |
Why?
|
Receptors, CCR4 | 1 | 2013 | 77 | 0.030 |
Why?
|
Lipopolysaccharides | 2 | 2012 | 2206 | 0.030 |
Why?
|
Karyopherins | 1 | 2013 | 133 | 0.030 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2013 | 100 | 0.030 |
Why?
|
Intradermal Tests | 1 | 2012 | 42 | 0.030 |
Why?
|
Ventricular Function, Right | 1 | 2017 | 617 | 0.030 |
Why?
|
Obesity | 1 | 2015 | 12947 | 0.030 |
Why?
|
Cell Death | 1 | 2018 | 1679 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20568 | 0.030 |
Why?
|
Azepines | 1 | 2014 | 329 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 1998 | 2231 | 0.030 |
Why?
|
Macrophages, Peritoneal | 1 | 2013 | 238 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4576 | 0.020 |
Why?
|
Cell Line | 2 | 2019 | 15601 | 0.020 |
Why?
|
Zebrafish | 2 | 2014 | 3008 | 0.020 |
Why?
|
Membrane Lipids | 1 | 2013 | 252 | 0.020 |
Why?
|
Microscopy, Fluorescence | 2 | 2013 | 2645 | 0.020 |
Why?
|
Phosphorus | 1 | 2013 | 335 | 0.020 |
Why?
|
3T3-L1 Cells | 1 | 2012 | 209 | 0.020 |
Why?
|
Phosphatidylserines | 1 | 2013 | 188 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2013 | 740 | 0.020 |
Why?
|
Durapatite | 1 | 2013 | 163 | 0.020 |
Why?
|
Chemokine CCL20 | 1 | 2012 | 64 | 0.020 |
Why?
|
Acetylation | 1 | 2014 | 1055 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2005 | 5112 | 0.020 |
Why?
|
Brazil | 1 | 2015 | 1230 | 0.020 |
Why?
|
Bleeding Time | 1 | 2011 | 83 | 0.020 |
Why?
|
Mice, Obese | 1 | 2012 | 420 | 0.020 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2014 | 373 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2017 | 2510 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 12149 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2012 | 470 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2016 | 1674 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2008 | 9177 | 0.020 |
Why?
|
K562 Cells | 1 | 2012 | 642 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2014 | 790 | 0.020 |
Why?
|
Extracellular Space | 1 | 2012 | 563 | 0.020 |
Why?
|
Models, Cardiovascular | 1 | 2016 | 981 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1612 | 0.020 |
Why?
|
RNA Polymerase II | 1 | 2014 | 539 | 0.020 |
Why?
|
Complement C3a | 1 | 2010 | 66 | 0.020 |
Why?
|
Immunoblotting | 1 | 2013 | 1646 | 0.020 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2015 | 823 | 0.020 |
Why?
|
Chemotaxis | 1 | 2013 | 598 | 0.020 |
Why?
|
Adenosine Diphosphate | 1 | 2011 | 422 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2017 | 2115 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2015 | 771 | 0.020 |
Why?
|
Gene Knock-In Techniques | 1 | 2011 | 421 | 0.020 |
Why?
|
Heart | 1 | 2023 | 4404 | 0.020 |
Why?
|
Complement C5a | 1 | 2010 | 100 | 0.020 |
Why?
|
Receptor, Anaphylatoxin C5a | 1 | 2010 | 87 | 0.020 |
Why?
|
Cyclic GMP | 1 | 2011 | 395 | 0.020 |
Why?
|
Binding Sites | 1 | 1998 | 6056 | 0.020 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2012 | 577 | 0.020 |
Why?
|
Carotid Stenosis | 1 | 2017 | 860 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2012 | 605 | 0.020 |
Why?
|
Cardiovascular Agents | 1 | 2016 | 840 | 0.020 |
Why?
|
Acetaminophen | 1 | 2014 | 555 | 0.020 |
Why?
|
Receptors, LDL | 1 | 2012 | 488 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2012 | 6534 | 0.020 |
Why?
|
Receptors, Complement | 1 | 2010 | 253 | 0.020 |
Why?
|
Triazoles | 1 | 2014 | 903 | 0.020 |
Why?
|
Survival Rate | 2 | 2017 | 12723 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2805 | 0.020 |
Why?
|
Fibrosis | 1 | 2016 | 2049 | 0.020 |
Why?
|
Glutathione | 1 | 2011 | 583 | 0.020 |
Why?
|
Embryonic Development | 1 | 2013 | 721 | 0.020 |
Why?
|
Disease Progression | 2 | 2016 | 13510 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2015 | 1814 | 0.020 |
Why?
|
Cell Cycle | 1 | 2016 | 2932 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2016 | 1664 | 0.020 |
Why?
|
Toxoplasmosis | 1 | 2008 | 94 | 0.020 |
Why?
|
United States | 3 | 2022 | 72340 | 0.020 |
Why?
|
Chemokines | 1 | 2012 | 959 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2011 | 1496 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2014 | 1363 | 0.020 |
Why?
|
Aortic Valve Insufficiency | 1 | 2012 | 576 | 0.020 |
Why?
|
Placenta | 1 | 2017 | 1709 | 0.020 |
Why?
|
Adult | 4 | 2022 | 221210 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2012 | 744 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2011 | 1341 | 0.020 |
Why?
|
Zebrafish Proteins | 1 | 2014 | 1015 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 1779 | 0.020 |
Why?
|
Ferric Compounds | 1 | 2009 | 378 | 0.020 |
Why?
|
Triglycerides | 1 | 2015 | 2461 | 0.020 |
Why?
|
Transcription, Genetic | 2 | 2014 | 7593 | 0.020 |
Why?
|
Swine | 1 | 2017 | 5915 | 0.020 |
Why?
|
Fluorescence | 1 | 2009 | 756 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 22173 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2015 | 1376 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1642 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14665 | 0.020 |
Why?
|
Muscle, Skeletal | 2 | 2011 | 4948 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 7968 | 0.020 |
Why?
|
Pyridines | 1 | 2017 | 2875 | 0.020 |
Why?
|
Carrier Proteins | 1 | 1999 | 4937 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8225 | 0.020 |
Why?
|
Adipocytes | 1 | 2012 | 1194 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2009 | 1085 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2014 | 2136 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2017 | 3807 | 0.010 |
Why?
|
Administration, Oral | 1 | 2012 | 4021 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2013 | 1600 | 0.010 |
Why?
|
Transfection | 1 | 2012 | 5774 | 0.010 |
Why?
|
RNA Interference | 1 | 2013 | 2832 | 0.010 |
Why?
|
Autoimmunity | 1 | 2012 | 1356 | 0.010 |
Why?
|
Sodium-Calcium Exchanger | 1 | 2004 | 89 | 0.010 |
Why?
|
Cell Count | 1 | 2008 | 1835 | 0.010 |
Why?
|
Sirolimus | 1 | 2011 | 1533 | 0.010 |
Why?
|
Immunoglobulin G | 2 | 2008 | 4544 | 0.010 |
Why?
|
Massachusetts | 1 | 2017 | 8833 | 0.010 |
Why?
|
Histones | 1 | 2014 | 2580 | 0.010 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2006 | 898 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3430 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2015 | 8181 | 0.010 |
Why?
|
Organ Specificity | 1 | 2008 | 1968 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2017 | 12341 | 0.010 |
Why?
|
Incidence | 1 | 2022 | 21355 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4125 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 2139 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4281 | 0.010 |
Why?
|
Antioxidants | 1 | 2011 | 1668 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2012 | 1886 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8466 | 0.010 |
Why?
|
Lectins, C-Type | 1 | 2006 | 585 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 1903 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8554 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10090 | 0.010 |
Why?
|
Chromatin | 1 | 2014 | 2961 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2013 | 2118 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2015 | 3085 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8633 | 0.010 |
Why?
|
Young Adult | 2 | 2022 | 59260 | 0.010 |
Why?
|
Probability | 1 | 2007 | 2477 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2850 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2007 | 2927 | 0.010 |
Why?
|
Megakaryocytes | 1 | 2006 | 567 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 2898 | 0.010 |
Why?
|
Pregnancy | 2 | 2017 | 29890 | 0.010 |
Why?
|
Cross-Linking Reagents | 1 | 2004 | 687 | 0.010 |
Why?
|
Models, Animal | 1 | 2008 | 2112 | 0.010 |
Why?
|
Down-Regulation | 1 | 2008 | 2919 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5247 | 0.010 |
Why?
|
Myocardial Ischemia | 1 | 2011 | 2113 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 80647 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2013 | 3879 | 0.010 |
Why?
|
Insulin | 1 | 2015 | 6597 | 0.010 |
Why?
|
Reference Values | 1 | 2007 | 4920 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2012 | 3313 | 0.010 |
Why?
|
Anti-Infective Agents | 1 | 2007 | 983 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 5790 | 0.010 |
Why?
|
Calcium Signaling | 1 | 2004 | 733 | 0.010 |
Why?
|
Anticoagulants | 1 | 2015 | 4812 | 0.010 |
Why?
|
Qc-SNARE Proteins | 1 | 1999 | 20 | 0.010 |
Why?
|
Qb-SNARE Proteins | 1 | 1999 | 34 | 0.010 |
Why?
|
Tetanus Toxin | 1 | 1999 | 46 | 0.010 |
Why?
|
Qa-SNARE Proteins | 1 | 1999 | 52 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 9001 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2007 | 22176 | 0.010 |
Why?
|
R-SNARE Proteins | 1 | 1999 | 75 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2009 | 3769 | 0.010 |
Why?
|
Lasers | 1 | 2003 | 952 | 0.010 |
Why?
|
Cell Communication | 1 | 2005 | 1657 | 0.010 |
Why?
|
Microcirculation | 1 | 2003 | 1272 | 0.010 |
Why?
|
Coronary Disease | 1 | 2012 | 5914 | 0.010 |
Why?
|
Blood Coagulation | 1 | 2003 | 1154 | 0.010 |
Why?
|
Genotype | 1 | 2011 | 12990 | 0.010 |
Why?
|
Gene Targeting | 1 | 1999 | 838 | 0.010 |
Why?
|
Acute Disease | 1 | 2006 | 7237 | 0.010 |
Why?
|
Mutation | 1 | 1999 | 30053 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 29629 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9469 | 0.010 |
Why?
|
Gene Deletion | 1 | 1999 | 2665 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 36426 | 0.000 |
Why?
|